Bluejay Diagnostics Files Definitive Proxy Statement
Ticker: BJDX · Form: DEF 14A · Filed: May 16, 2025 · CIK: 1704287
Sentiment: neutral
Topics: proxy-statement, governance, shareholder-meeting
TL;DR
Bluejay Diagnostics proxy filed, shareholders vote on directors & auditors June 18.
AI Summary
Bluejay Diagnostics, Inc. filed its definitive proxy statement on May 16, 2025, for its annual meeting of stockholders scheduled for June 18, 2025. The filing outlines the company's governance, executive compensation, and proposals to be voted on by shareholders. Key items likely include the election of directors and ratification of independent auditors.
Why It Matters
This filing provides shareholders with crucial information to make informed voting decisions on company leadership and strategic direction at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) that provides information to shareholders and does not inherently represent new financial risk.
Key Numbers
- DEF 14A — Filing Type (Definitive Proxy Statement)
Key Players & Entities
- Bluejay Diagnostics, Inc. (company) — Registrant
- 0001213900-25-044931 (filing_id) — Accession Number
- 20250516 (date) — Filing Date
- 20250618 (date) — Meeting Date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxy votes from shareholders for their annual or special meetings, providing details on matters to be voted upon, such as director elections and executive compensation.
When is the Bluejay Diagnostics, Inc. annual meeting scheduled?
The annual meeting of stockholders for Bluejay Diagnostics, Inc. is scheduled for June 18, 2025.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on May 16, 2025.
What is the Central Index Key (CIK) for Bluejay Diagnostics, Inc.?
The Central Index Key (CIK) for Bluejay Diagnostics, Inc. is 0001704287.
Where is Bluejay Diagnostics, Inc. headquartered?
Bluejay Diagnostics, Inc. is located at 360 Massachusetts Avenue, Suite 203, Acton, MA 01720.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 16, 2025 regarding Bluejay Diagnostics, Inc. (BJDX).